Another study demonstrated the clinical outcome of HNSCC patients was significantly associated with CTC number and circulating cancer stem-like cells (cCSCs) ratio, but not PD-1 expression on peripheral CD4+, CD8+, or CD56+ cells [122]. The gene discussed is PDCD1; the disease is cancer.